SCLZ:BATS-Swan Enhanced Dividend Income ETF (USD)

ETF | Others |

Last Closing

USD 53.658

Change

+0.23 (+0.44)%

Market Cap

USD 6.76M

Volume

6.40K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-17 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
FBTC Fidelity Wise Origin Bitcoin T..

+3.95 (+4.50%)

USD 19.65B
INDA iShares MSCI India ETF

+0.13 (+0.25%)

USD 10.11B
PAVE Global X U.S. Infrastructure D..

+0.35 (+0.82%)

USD 8.80B
BUFR First Trust Cboe Vest Fund of ..

+0.14 (+0.46%)

USD 6.08B
ARKB ARK 21Shares Bitcoin ETF

+4.37 (+4.36%)

USD 4.54B
BOXX Alpha Architect 1-3 Month Box ..

+0.06 (+0.05%)

USD 4.52B
BBUS JPMorgan BetaBuilders U.S. Equ..

+1.03 (+0.96%)

USD 4.22B
KNG FT Cboe Vest S&P 500® Dividen..

+0.12 (+0.24%)

USD 3.45B
IFRA iShares U.S. Infrastructure ET..

+0.20 (+0.41%)

USD 3.24B
GSUS Goldman Sachs MarketBeta US Eq..

+0.82 (+1.00%)

USD 2.46B

ETFs Containing SCLZ

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.79% 34% F 35% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.79% 34% F 34% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 6.76M 23% F 21% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.